Chimeric Antigen Receptor T Cells Targeting claudin18.2 in Solid Tumors.
Clinical trial NCT03874897 · COMPLETED
Trial details
- NCT number
- NCT03874897
- Sponsor
- Peking University
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-03-26
- Primary completion
- 2021-03-20
- Enrollment
- 134
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.